Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/17229633

Download in:

View as

General Info

PMID
17229633